Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1CNS 1

Conditions

Neoplasms 1Meningioma 1Leukemia, Hairy Cell 1Diabetes Mellitus 1Brain Neoplasms 1

Interventions

Cyclophosphamide 909Carboplatin 787pembrolizumab 744Paclitaxel 742Cisplatin 709Bevacizumab 706Gemcitabine 619Docetaxel 579Rituximab 548Radiotherapy 541Dexamethasone 511Nivolumab 488Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 358Pemetrexed 337Cytarabine 335Oxaliplatin 333Lenalidomide 328Prednisone 326fludarabine phosphate 316Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 276

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Has results × Verapamil × Clear all
NCT04233034 2024-11-27

CLVer

Jaeb Center for Health Research

Phase 3 Completed
113 enrolled 42 charts
Other hematologic neoplasm

Diabetes Mellitus, Leukemia, Hairy Cell

NCT00706810 2017-04-13

Combination of Hydroxyurea and Verapamil for Refractory Meningiomas

University of Utah

Phase 2 Completed
8 enrolled 5 charts
CNS

Brain Neoplasms, Meningioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡